Table A2.
Disease Subtypes Currently Represented on HemOnc.org, With No. of Regimens for Each Subtype (excludes regimen variants)
| Subtype | No. of Regimens |
|---|---|
| Benign hematology | |
| Aplastic anemia | 1 |
| Autoimmune thrombocytopenic purpura | 6 |
| Castleman's disease | 1 |
| Paroxysmal nocturnal hemoglobinuria | 2 |
| Malignant hematology | |
| Acute lymphocytic leukemia | 23 |
| Ph positive | |
| Ph negative | |
| Acute myeloid leukemia | 41 |
| Acute promyelocytic leukemia | 22 |
| Aggressive non-Hodgkin lymphoma | 68 |
| DLBCL | |
| Burkitt's lymphoma | |
| Primary mediastinal B-cell lymphoma | |
| Gastric DLBCL | |
| Chronic lymphocytic leukemia and small lymphocytic lymphoma | 55 |
| Chronic myelogenous leukemia | 25 |
| Chronic phase | |
| Accelerated phase | |
| Blast crisis | |
| Chronic myelomonocytic leukemia | 1 |
| CNS lymphoma | 7 |
| Essential thrombocythemia | 2 |
| Follicular lymphoma | 51 |
| Hairy cell leukemia | 5 |
| HIV-associated lymphoma | 9 |
| Hodgkin lymphoma | 26 |
| Hodgkin lymphoma, nodular lymphocyte-predominant | 8 |
| Large granular lymphocytic leukemia | 2 |
| Light-chain amyloidosis | 14 |
| Mantle cell lymphoma | 29 |
| Marginal zone lymphoma | 20 |
| Multiple myeloma | 52 |
| Myelodysplastic syndrome | 10 |
| Myelofibrosis | 6 |
| Polycythemia vera | 1 |
| T-cell lymphoma | 28 |
| Anaplastic large-cell lymphoma | |
| Cutaneous T-cell lymphoma | |
| Extranodal NK/T-cell lymphoma, nasal type | |
| NK/T-cell lymphoma | |
| Peripheral T-cell lymphoma NOS | |
| Waldenström macroglobulinemia | 11 |
| Other | |
| Transplantation conditioning regimens | 18 |
| Autologous stem-cell transplantation | |
| Allogeneic stem-cell transplantation | |
| Solid oncology | |
| Anal cancer | 4 |
| Basal cell and squamous cell skin cancer | 8 |
| Basal cell carcinoma | |
| Squamous cell carcinoma | |
| Bladder cancer | 27 |
| Bone cancer | 28 |
| Chondrosarcoma | |
| Ewing's sarcoma | |
| Osteosarcoma | |
| Malignant fibrous histiocytoma of bone | 94 |
| Breast cancer | |
| HER2 negative | |
| HER2 positive | |
| CNS cancer | 35 |
| Anaplastic glioma | |
| Glioblastoma multiforme | |
| Oligodendroglioma | |
| Supratentorial astrocytoma | |
| Cervical cancer | 27 |
| Colon cancer | 34 |
| Esophageal cancer | 79 |
| Gastric cancer | 6 |
| Head and neck cancer | 31 |
| Hepatobiliary cancer | 24 |
| Hepatocellular carcinoma | |
| Biliary tract cancer | |
| Melanoma | 27 |
| Mesothelioma | 11 |
| Neuroendocrine tumors | 29 |
| Adrenal gland tumors | |
| Carcinoid tumors | |
| Pancreatic neuroendocrine islet cell tumors | |
| Pheochromocytoma | |
| Non–small-cell lung cancer | 39 |
| Ovarian cancer | 31 |
| Pancreatic cancer | 21 |
| Penile cancer | 11 |
| Prostate cancer | 36 |
| Rectal cancer | 9 |
| Renal cancer | 18 |
| Sarcoma | 27 |
| Angiosarcoma | |
| GI stromal tumor | |
| Giant-cell tumor of bone | |
| Kaposi sarcoma | |
| Various other histologies | |
| Small-cell lung cancer | 27 |
| Testicular cancer | 17 |
| Pure seminoma | |
| Nonseminoma | |
| Thymoma | 9 |
| Thyroid cancer | 8 |
| Medullary | |
| Various other histologies | |
| Unknown primary | 14 |
| Adenocarcinoma or carcinoma NOS | |
| Squamous cell carcinoma | |
| Neuroendocrine | |
| Uterine cancer | 23 |
| Endometrioid | |
| Various other histologies | |
| Total | 1,298 |
Abbreviations: DLBCL, diffuse large B-cell lymphoma; HER2, human epidermal growth factor receptor 2; NK, natural killer; NOS, not otherwise specified.